Vander Poorten et al developed 2 prognostic scores for patients with parotid carcinoma. The first used clinical information while the second included information from the pathologic examination of the tumor. The work was done at the Netherlands Cancer Institute in Amsterdam.
Prognostic Score from Clinical Findings (PS1)
Parameter |
Finding |
Points |
---|---|---|
age at diagnosis |
age in years |
age |
pain on presentation |
no pain |
1 |
|
pain or numbness |
2 |
T status of clinical TNM |
T1 |
0 |
|
T2 |
1 |
|
T3 |
2 |
|
T4 |
3 |
N status of clinical TNM |
N0 |
0 |
|
N1 |
1 |
|
N2a |
2 |
|
N2b |
3 |
|
N2c |
4 |
|
N3 |
5 |
skin invasion |
no invasion |
1 |
|
present |
2 |
facial nerve dysfunction |
intact function |
1 |
|
paresis and/or paralysis |
2 |
prognostic score 1 (PS1) =
= (0.024 * (age in years)) + (0.62 * (points for pain)) + (0.44 * (points for T status)) + (0.45 * (points for N status)) + (0.63 * (points for skin invasion)) + (0.91 * (points for facial nerve dysfunction))
Interpretation:
• minimum score: around 2.64
• maximum score: around 10
• 4 prognostic groups identified with different 5 year recurrence free survival.
PS1 |
Group |
5 year recurrence free rates (95% CI) |
---|---|---|
< 3.85 |
1 |
92.4% (73.0-98.1%) |
3.85 - 4.74 |
2 |
82.5% (62.8-92.4%) |
4.75 - 5.80 |
3 |
48.1% (26.1 - 67.1%) |
> 5.80 |
4 |
22.8% (8.5-41.2%) |
Prognostic Score After Examination of Resected Specimen (PS2)
Parameter |
Finding |
Points |
---|---|---|
age at diagnosis |
age in years |
age |
T status of clinical TNM |
T1 |
0 |
|
T2 |
1 |
|
T3 |
2 |
|
T4 |
3 |
N status of clinical TNM |
N0 |
0 |
|
N1 |
1 |
|
N2a |
2 |
|
N2b |
3 |
|
N2c |
4 |
|
N3 |
5 |
skin invasion |
no invasion |
1 |
|
present |
2 |
facial nerve dysfunction |
intact function |
1 |
|
paresis and/or paralysis |
2 |
perineural growth in the resected specimen |
no |
1 |
|
yes |
2 |
positive surgical margins |
no |
1 |
|
yes |
2 |
prognostic score 2 (PS2) =
= (0.018 * (age in years)) + (0.39 * (points for T status)) + (0.34 * (points for N status)) + (0.70 * (points for skin invasion)) + (0.56 * (points for facial nerve dysfunction)) + (0.78 * (points for perineural growth)) + (0.65 * (points for positive margin))
Interpretation:
• minimum score: around 2.35
• maximum score: around 10
• 4 prognostic groups identified with different 5 year recurrence free survival.
PS2 |
Group |
5 year recurrence free rates (95% CI) |
---|---|---|
< 3.99 |
1 |
95% (69.5-99.3%) |
3.99 - 4.80 |
2 |
82.5% (59.8-93.1%) |
4.81 - 5.67 |
3 |
55.9% (30.8 - 75.1%) |
> 5.67 |
4 |
42% (21.9-60.9%) |
Specialty: Hematology Oncology, Surgery, general, Otolaryngology